PMID- 33749789 OWN - NLM STAT- MEDLINE DCOM- 20221202 LR - 20221202 IS - 2042-7158 (Electronic) IS - 0022-3573 (Linking) VI - 74 IP - 12 DP - 2022 Nov 25 TI - Systemic administration of sunflower oil exerts neuroprotection in a mouse model of transient focal cerebral ischaemia. PG - 1776-1783 LID - 10.1093/jpp/rgab007 [doi] AB - OBJECTIVES: Natural products are valuable sources of nutraceuticals for the prevention or treatment of ischemic stroke, a major cause of death and severe disability worldwide. Among the mechanisms implicated in cerebral ischemia-reperfusion damage, oxidative stress exerts a pivotal role in disease progression. Given the high antioxidant potential of most components of sunflower oil, we have explored its effects on ischemic brain injury produced in the mouse by transient occlusion of the middle cerebral artery (MCAo). KEY FINDINGS: Intraperitoneal (i.p.) administration of sunflower oil at doses of 3 ml/kg (48 h, 24 h and 1 h before MCAo) significantly reduced brain infarct volume and oedema assessed 24 h after the insult. This neuroprotective treatment schedule also prevented the elevation of brain lipid peroxidation produced by MCAo-reperfusion injury. By contrast, doses of 0.03 ml/kg of sunflower oil resulted ineffective on both cerebral damage and lipid peroxidation. Although sunflower oil did not affect serum levels of Diacron-reactive oxygen metabolites (d-ROMs), both 0.03 and 3 ml/kg dosing regimens resulted in the preservation of serum biological antioxidant potential (BAP) that was otherwise dramatically reduced 24 h after MCAo. CONCLUSIONS: Sunflower oil represents a promising source of neuroprotective extracts/compounds that can be exploited for the prevention and/or treatment of cerebral ischemia. CI - (c) The Author(s) 2021. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - La Russa, Daniele AU - La Russa D AD - Section of Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Cosenza, Italy. FAU - Montesano, Domenico AU - Montesano D AD - Department of Pharmaceutical Sciences, Section of Food Science and Nutrition, University of Perugia, Perugia, Italy. FAU - Pellegrino, Daniela AU - Pellegrino D AD - Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, Cosenza, Italy. FAU - Frisina, Marialaura AU - Frisina M AD - Section of Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Cosenza, Italy. FAU - Bagetta, Giacinto AU - Bagetta G AD - Section of Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Cosenza, Italy. FAU - Fallarino, Francesca AU - Fallarino F AD - Department of Experimental Medicine, University of Perugia, Perugia, Italy. FAU - Amantea, Diana AU - Amantea D AUID- ORCID: 0000-0002-7513-3495 AD - Section of Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, Cosenza, Italy. LA - eng PT - Journal Article PL - England TA - J Pharm Pharmacol JT - The Journal of pharmacy and pharmacology JID - 0376363 RN - 0 (Sunflower Oil) RN - 0 (Antioxidants) RN - 0 (Neuroprotective Agents) SB - IM MH - Animals MH - Mice MH - Neuroprotection MH - Sunflower Oil/metabolism/pharmacology/therapeutic use MH - Antioxidants/metabolism MH - *Neuroprotective Agents MH - *Ischemic Attack, Transient/drug therapy/prevention & control/metabolism MH - *Brain Ischemia/drug therapy/prevention & control/metabolism MH - Disease Models, Animal MH - Brain MH - Infarction, Middle Cerebral Artery/drug therapy/metabolism OTO - NOTNLM OT - brain ischemia OT - lipid peroxidation OT - neuroprotection OT - oxidative stress OT - sunflower oil OT - vitamin E EDAT- 2021/03/23 06:00 MHDA- 2022/12/03 06:00 CRDT- 2021/03/22 12:49 PHST- 2020/11/02 00:00 [received] PHST- 2021/01/13 00:00 [accepted] PHST- 2021/03/23 06:00 [pubmed] PHST- 2022/12/03 06:00 [medline] PHST- 2021/03/22 12:49 [entrez] AID - 6179829 [pii] AID - 10.1093/jpp/rgab007 [doi] PST - ppublish SO - J Pharm Pharmacol. 2022 Nov 25;74(12):1776-1783. doi: 10.1093/jpp/rgab007.